Paul Conlin, MD

Adjunct Professor, Boston University Chobanian & Avedisian School of Medicine

Biography

Dr. Conlin is Chief, Medical Service at VA Boston Healthcare System, Professor of Medicine at Harvard Medical School and Maurice Strauss Chair at Chobanian and Avedisian School of Medicine. He is also Director of the Clinical and Translational Research Academy in Harvard Catalyst - The Harvard Clinical and Translational Science Center. Dr. Conlin has been a practicing endocrinologist at VA Boston since 1989 and is Chair, VA Diabetes-Endocrinology Field Advisory Committee. His research focuses on improving patient-centered care for individuals with diabetes mellitus using information technology and health services approaches.

He has conducted clinical trials on the effects of dietary patterns and blood pressure regulation and studied patients with poorly controlled diabetes using e-health platforms and care management. He was a key architect of the VA’s national teleretinal imaging program to screen for diabetic retinopathy. His current research uses health services approaches to study clinical outcomes in patients with diabetes, focusing on hemoglobin A1c variability and medication cost-effectiveness.

Publications

  • Published 5/1/2026

    Conlin PR, Prentice JC, Mohr DC, Zhang L, Li D, Pleasants E, Nelson RE, Vupputuri S, Nichols GA. Haemoglobin A1c Time-In-Range and Mortality in Adults With Diabetes. Endocrinol Diabetes Metab. 2026 May; 9(3):e70197. PMID: 41904972.

    Read at: PubMed

  • Published 11/4/2025

    Conlin PR, Prentice JC, Mohr DC, Zhang L, Li D, Pleasants E, Nelson RE, Vupputuri S, Nichols GA. Hemoglobin A1c time-in-range, mortality, and diabetes complications in older adults with diabetes. BMJ Open Diabetes Res Care. 2025 Nov 04; 13(6). PMID: 41192934.

    Read at: PubMed

  • Published 3/8/2025

    Vimalananda VG, Kragen B, Leibowitz AJ, Qian S, Wormwood J, Linsky AM, Underwood P, Conlin PR, Kim B. Determinants of implementation of continuous glucose monitoring for patients with Insulin-Treated type 2 diabetes: a national survey of primary care providers. BMC Prim Care. 2025 Mar 08; 26(1):68. PMID: 40057678.

    Read at: PubMed

  • Published 8/1/2024

    Underwood PC, Zhang L, Mohr DC, Prentice JC, Nelson RE, Budson AE, Conlin PR. Glycated Hemoglobin A1c Time in Range and Dementia in Older Adults With Diabetes. JAMA Netw Open. 2024 Aug 01; 7(8):e2425354. PMID: 39093563.

    Read at: PubMed

  • Published 7/5/2024

    Conlin PR, Burke BV, Hobbs C, Hurren KM, Lang AE, Morrison JW, Spacek L, Steil EN, Watts SA, Weinreb JE, Pogach LM. Management of Type 2 Diabetes Mellitus: Synopsis of the Department of Veterans Affairs and Department of Defense Clinical Practice Guideline. Mayo Clin Proc. 2024 Jul 05. PMID: 39093266.

    Read at: PubMed

Education

  • University of Massachusetts Medical School, MD
  • Boston College, BS